Bec Crew @beccrew.bsky.social · 17/04/2026This breakdown of institutions' research output by cancer type appears in our latest Nature Index supplement. We also highlight the cancer types that are growing in publications the fastest: go.nature.com/487Pyzz 020
Bec Crew @beccrew.bsky.social · 07/05/2025Harvard dominates high-quality cancer research publishing, having widened the gap between itself and the Chinese Academy of Sciences dramically over the past few years. go.nature.com/3EoPuQi 000
Bec Crew @beccrew.bsky.social · 06/05/2025The US is responsible for more than half of the global public and philanthropic funding for cancer research. Funding cuts, like we've seen recently under Trump, pose a serious risk to new tests and treatments: go.nature.com/3EoPuQi 001
Bec Crew @beccrew.bsky.social · 06/05/2025Chinese companies have overtaken the US in cancer clinical trial starts. Its rise to the top is unlike anything we've seen from other leading science nations: go.nature.com/3EoPuQi 33811
